Aquaculture Vaccines Market - By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasitic Vaccines. By Application: Fish, Shrimp, Mollusks, Others. By End-user: Aquaculture Farms, Veterinary Clinics, Research Institutes. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
The global Aquaculture Vaccines Market was valued at 1.8 billion in 2023 and is projected to reach 4.2 billion by 2031, growing at a CAGR of 11.2%. Rising seafood demand, antibiotic reduction policies, and novel vaccine technologies are driving growth.
2024 Market Breakthroughs
Market Drivers
1. Antibiotic Reduction Mandates
2. Disease Burden
3. Production Intensification
Competitive Landscape
|
Company |
Market Share |
Flagship Product |
Strategic Edge |
|
Zoetis |
30% |
AlphaJect® vaccines |
Salmon market leader |
|
PHARMAQ (Merck) |
25% |
Norvax® line |
Oral delivery expertise |
|
Vaxxinova |
20% |
BioOral platform |
Yeast-vectored vaccines |
Emerging Disruptors:
Market Segmentation
Recent Developments (2024)
Need help?
Chat with our team in a minute.